Following Q1 results, Roth Capital analyst Eric Handler told investors in a research note that Cinemark (CNK) is as an attractive, defensive asset that is just entering the start of what should be a two year plus positive content cycle. As the box office grows, margins should expand and cash flow should increase, thereby creating the potential for a higher level of capital returns, the firm added. Roth Capital reiterates a Buy rating and $36 price target on Cinemark shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue